Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,524 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prostate Cancer Patient With Lymph-node Metastasis Treated Only With Methionine Restriction Has Stable Disease for Two Years Demonstrated With PET/CT and PSMA-PET Scanning and PSA Testing.
Morinaga S, Han Q, Mizuta K, Kang BM, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Higuchi T, Tsuchiya H, Demura S, Hoffman RM. Morinaga S, et al. Among authors: hoffman rm. Cancer Diagn Progn. 2025 Jan 3;5(1):27-31. doi: 10.21873/cdp.10408. eCollection 2025 Jan-Feb. Cancer Diagn Progn. 2025. PMID: 39758238 Free PMC article.
Elevated-c-MYC-expressing Fibrosarcoma Cells With Acquired Gemcitabine Resistance Remain Sensitive to Recombinant Methioninase: A Potential Clinical Strategy for a Recalcitrant Disease.
Morinaga S, Han Q, Mizuta K, Kang BM, Bouvet M, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Higuchi T, Tsuchiya H, Demura S, Hoffman RM. Morinaga S, et al. Among authors: hoffman rm. Cancer Diagn Progn. 2025 Jan 3;5(1):8-14. doi: 10.21873/cdp.10405. eCollection 2025 Jan-Feb. Cancer Diagn Progn. 2025. PMID: 39758233 Free PMC article.
Complete Response (CR) in a Previously-progressing Chronic Lymphocytic Leukemia (CLL) Patient Treated With Methionine Restriction in Combination With First-line Chemotherapy.
Morinaga S, Han Q, Mizuta K, Kang BM, Yamamoto N, Hayashi K, Kimura H, Miwa S, Igarashi K, Higuchi T, Tsuchiya H, Demura S, Hoffman RM. Morinaga S, et al. Among authors: hoffman rm. Cancer Diagn Progn. 2025 Jan 3;5(1):21-26. doi: 10.21873/cdp.10407. eCollection 2025 Jan-Feb. Cancer Diagn Progn. 2025. PMID: 39758229 Free PMC article.
Subsequent pregnancies in the IMPAACT 2010/VESTED Trial: high rate of adverse outcomes in women living with HIV.
Fairlie L, Brummel S, Ziemba L, Coletti A, Chinula L, Shapiro R, Stringer J, Malonga G, Browning R, Chakhtoura N, Mmbaga BT, Mhembere TP, Omoz-Oarhe A, Nagaddya B, Naidoo M, Hoffman RM, Lockman S; IMPAACT 2010/VESTED Study Team. Fairlie L, et al. Among authors: hoffman rm. J Acquir Immune Defic Syndr. 2024 Oct;97(2):150-155. doi: 10.1097/qai.0000000000003473. J Acquir Immune Defic Syndr. 2024. PMID: 39742354 Clinical Trial.
Telemedicine for HIV care: a cross-sectional survey of people living with HIV receiving care at two federally qualified health centers in Los Angeles during a mature phase of the COVID-19 pandemic.
Walker D, Moucheraud C, Butler D, Takayama C, Shoptaw S, Currier JS, Gladstein J, Hoffman R. Walker D, et al. Among authors: hoffman r. BMC Infect Dis. 2024 Dec 31;24(1):1481. doi: 10.1186/s12879-024-10351-x. BMC Infect Dis. 2024. PMID: 39741230 Free PMC article.
4,524 results